We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+22.89%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$357M
AUM Growth
+$3K
Cap. Flow
-$4.39M
Cap. Flow %
-1.23%
Top 10 Hldgs %
47.67%
Holding
68
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$4.39M

Sector Composition

Rank Sector Weight
1 Technology 33.62%
2 Healthcare 24.24%
3 Financials 14.33%
4 Communication Services 7.36%
5 Consumer Discretionary 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
51
Berkshire Hathaway Class B
BRK.B
$1.07T
$603K 0.17%
3,300
ALXN
52
DELISTED
Alexion Pharmaceuticals
ALXN
$561K 0.16%
6,250
CI icon
53
Cigna
CI
$76.6B
$485K 0.14%
2,739
SHW icon
54
Sherwin-Williams
SHW
$78.3B
$437K 0.12%
2,850
ECL icon
55
Ecolab
ECL
$75.6B
$429K 0.12%
2,750
RGA icon
56
Reinsurance Group of America
RGA
$15.7B
$421K 0.12%
5,000
ABT icon
57
Abbott
ABT
$180B
$363K 0.1%
4,600
UNP icon
58
Union Pacific
UNP
$183B
$348K 0.1%
2,464
CLX icon
59
Clorox
CLX
$11.6B
$323K 0.09%
1,866
QRVO icon
60
Qorvo
QRVO
$7.63B
$305K 0.09%
3,783
AVGO icon
61
Broadcom
AVGO
$1.82T
$285K 0.08%
12,000
CTAS icon
62
Cintas
CTAS
$82.4B
$277K 0.08%
6,400
SRCL
63
DELISTED
Stericycle Inc
SRCL
$250K 0.07%
5,151
JNJ icon
64
Johnson & Johnson
JNJ
$635B
$236K 0.07%
1,800
BLD
65
DELISTED
TopBuild
BLD
$230K 0.06%
3,214
RGLD icon
66
Royal Gold
RGLD
$17.1B
$228K 0.06%
2,600
ANET icon
67
Arista Networks
ANET
$219B
$223K 0.06%
17,600
LIN icon
68
Linde
LIN
$237B
$208K 0.06%
1,200

Similar funds

De Burlo Group's Q2 2020 Portfolio in Review

As of Q2 2020, De Burlo Group held 68 positions worth $357M, up 0% from $357M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 0%. De Burlo Group opened no new positions and made no exits, leaving the 68-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • De Burlo Group's biggest Q2 2020 reduction was Edwards Lifesciences, cutting an estimated $4.39M.
  • De Burlo Group's ten largest holdings make up 48% of its $357M portfolio in Q2 2020.
  • De Burlo Group opened 0 new positions and closed 0 in Q2 2020.
  • De Burlo Group's portfolio value rose 0% quarter-over-quarter to $357M.

Based on De Burlo Group's 13F filing for Q2 2020, filed 6 Aug 2020.